This was the sentiment Lara Kotreleva heard over and over again when testing the waters on the possibility of hosting an art fair in Cyprus. The more she, together with co-founders Edgar Gadzhiev and ...

CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Vima Therapeutics, a clinical-stage biotechnology company focused on oral therapies for movement disorders, launched today with a $60M Series A ...

VIMA taps into Cyprus as a place of confluence of identities and a multicultural node, but the fair’s founders are cautious about overtly calling it political. Photo: Daria Makurina The days of the ...

Last week, the VIMA contemporary art fair opened its doors to the public for the first time in Limassol, Cyprus, ushering in waves of eager visitors looking for fresh insights into the island ...

TORONTO, ON and NEW YORK, NY / ACCESSWIRE / July 10, 2020 / Binovi Technologies Corp., (formerly Eyecarrot Innovations Corp) (Binovi) (TSX-V:VISN)(OTCQB:EYCCF), a leader in neuro-vision performance ...

Vima, the first international contemporary art fair in Cyprus, was a thrilling experience for the island and visiting collectors, curators and art lovers alike, both for the edgy location in a former ...

TORONTO, ON and NEW YORK, NY / ACCESSWIRE / July 20, 2020 / Binovi Technologies Corp., (Binovi) (TSX-V:VISN)(OTCQB:BNVIF), a leader in neuro-vision performance technology, is pleased to announce the ...

Over the last 11 months, Xiaomi has released tens of products via its Mijia crowdfunding platform. From sofas to refrigerators to cooking utensils, smart lamps, and TVs, Xiaomi is bent on taking over ...

- VIM0423, a potential first-in-class oral medicine for isolated dystonia, is currently being studied in a Phase 1 clinical trial; Phase 2 planned for fourth quarter of 2025 CAMBRIDGE, Mass., May 29, ...

(MENAFN- GlobeNewsWire - Nasdaq) - $60 million Series A led by Atlas Venture, and founded by an expert team of physicians and scientists - VIM0423, a potential first-in-class oral medicine for ...